Dupixent and Platelet count abnormal - a phase IV clinical study of FDA data

Summary:

Platelet count abnormal is reported as a side effect among people who take Dupixent (dupilumab), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Magnesium, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Platelet count abnormal when taking Dupixent. It is created by eHealthMe based on reports of 257,518 people who have side effects when taking Dupixent from the FDA, and is updated regularly.

What is Dupixent?

Dupixent has active ingredients of dupilumab. eHealthMe is studying from 257,631 Dupixent users. Check the latest studies of Dupixent.

What is Platelet count abnormal?

Platelet count abnormal is found to be associated with 538 drugs and 590 conditions by eHealthMe. Check the latest studies of Platelet count abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

257,518 people reported to have side effects when taking Dupixent.
Among them, 12 people (0.0%) have Platelet count abnormal.

Could Dupixent cause Platelet count abnormal?

Among these 12 people:

How long have people been on Dupixent when they have Platelet count abnormal? *

What is the gender of people who have Platelet count abnormal when taking Dupixent? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Platelet count abnormal when taking Dupixent? *

What are other drugs people take besides Dupixent? *

What are other side effects people have besides Platelet count abnormal? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 33.33%
Head Injury: 3 people, 25.00%
Vision Blurred: 3 people, 25.00%
Rash Pruritic (redness with itching): 2 people, 16.67%
Fatigue (feeling of tiredness): 2 people, 16.67%
Injection Site Pain: 2 people, 16.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 16.67%
Diplopia (double vision): 2 people, 16.67%
Dizziness: 2 people, 16.67%
Red Blood Cell Count Abnormal: 2 people, 16.67%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 58.33%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 1 person, 8.33%
Inflammation: 1 person, 8.33%
Immunodeficiency Common Variable: 1 person, 8.33%
Immunodeficiency: 1 person, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%
Asthma: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dupixent and have Platelet count abnormal?

- Check whether Platelet count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dupixent:

Dupixent (257,631 reports)

Browse all side effects of Dupixent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet count abnormal:

Platelet count abnormal (538 drugs)

Browse all the conditions that are associated with Platelet count abnormal:

Platelet count abnormal (590 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.